Research Projects

May 2022 – Nov. 2022

“Cost-effectiveness of COVID-19 vaccination in Benin and Ghana”, funded by Bill and Melinda Gates Foundation, $85,000

Nov. 2021 – Oct. 2023

“Assessing the opportunity costs of seasonal malaria chemoprevention in Burkina Faso, Mali, Senegal”, funded by Bill and Melinda Gates Foundation, approx. $1m

Aug. 2021 – Dec. 2025

 “supporting inclusive and accountable health systems decisions in Ghana and Kenya for universal health coverage (Support Systems), approximately 2.9 million Norwegian Krones, with Norwegian Institute for Public Health and KEMRI-Wellcome Trust Research Programme

Nov. 2020-Oct 2023

“Evaluation of African Health Diagnostics Platform”, Ghana Lead, funded by Bill and Melinda Gates Foundation, Led by John’s Hopkins Univ, approx. $3m

Aug. 2020 – Oct. 2021

“Assessing the economic implications of rotavirus vaccine switch in Ghana”, funded by PATH Seattle, Ghana PI, budget approx. $100,000

May 2020 – April 2025

“Community led Responsive and Effective Urban Health Systems (ChoRUS)”, Lead Inst: Leeds University, UK. Role: Ghana PI, Lead capacity building for Ghana & Nigeria. Total consortium budget approx. GBP7.9m, Ghana budget approx. GBP1m

April 2020 – Mar. 2024

“Developing Ghana’s care economy: case and potential”, co-PI (Lead Aarhus University, Denmark), funded by DANIDA, Approx. DKK10.25m

Oct. 2019 – Mar. 2020

“Analysis of interventions in development aid: Ghana and the Gavi graduation path”, co-PI, funded by International Decision Support Initiative, $27,000. Collaborating inst: Strathclyde University, Glasgow

Jun. 2019 - date

“Driving health progress during disease, demographic, domestic finance and donor transitions (the “4Ds”): policy analysis and engagement with transitioning countries”, Ghana country Lead. Collaboration institution: Duke Global Health Institute, USA. Funder: Bill and Melinda Gates Foundation

2018 - 2019

“Exploring the perspectives, experiences of in-country policymakers on transition from development assistance for health in Ghana and Sri Lanka”, Ghana Lead. Collaborating institution & funder; Duke Global Health Institute

2017-2018

“Economic assessment of malaria control interventions in Ghana”, funded by Global Fund through National Malaria Control Programme, Ghana. US$144,015.35

Jul. 2016 – Jan. 2017

“National responses to global health targets: exploring policy transfer in the context of the UNAIDS ‘90-90-90’ treatment targets in Ghana and Uganda”, funded by HIV Modelling Consortium, Imperial College London (collaborating institution), Ghana PI, US$7,500

Mar. – Sep. 2015

“Economic burden of malaria on businesses in Ghana: an economic case for investing in malaria control”, funded by DFID Ghana through National Malaria Control Programme, approx. US$70,000

Mar. 2015 – Dec. 2015

“Fiscal implications for health financing in African countries recently graduating from low to lower-middle income status: the case of Ghana and Kenya”. Funded by Bill & Melinda Gates Foundation through African Health Economics and Policy Association (AfHEA), Study PI, US$42,000. Collaborating institution: Lancet Commission for Investing in Health, University of California San Francisco, USA

Dec 2014 – Feb 2016

“Cost of implementation of malaria vaccination programs in five select sub-Saharan African countries (Burkina Faso, Ghana, Kenya, Mozambique, Tanzania)”, Ghana Country PI, funded by GSK Vaccines, Total Budget approx. Euro 100,000. Collaborator institution: ISGlobal, University of Barcelona, Spain

Co-Investigator

2018-2019

“The economic impact of pediatric surgeries in St. Vincent and the Grenadines”, funding from World Pediatric Foundation, USA. Budget US$22,282. Collaborator institution: College of William & Mary, Williamsburg, USA

2014-2015

“Programmatically and routinely costing malaria service delivery in Ghana”, Bill & Melinda Gates Foundation through Swiss Tropical & Public Health Institute, University of Basel, US$50,000

Mar. 2013 – Aug. 2013

“Evaluation of the Ghana-Diagnostic Related Grouping (G-DRG) payment system of the Ghana National Health Insurance Scheme”, funded by World Bank Health Insurance Project Ghana, approx. US$150,000

2008 – 2010

Efficiency of hospitals in Bostwana, (Funded by World Health Organization, Regional Office for Africa), US$20,000

2019 - 2020

Benefit-cost analysis of mental health interventions in Ghana: an investment case, Consultant for Copenhagen consensus Centre, under Ghana Priorities Project

2019 - 2020

Cost-effectiveness analysis and budget impact of introducing HPV vaccines in Ghana, Consultant for PATH, Seattle

Jul. – Dec. 2019 

Developing health financing progress matrix for Ghana, Consultant for WHO Geneva

Nov 2018 – Jul. 2020

Political economy of domestic financing of traditional vaccines and vitamin A supplement in six Eastern and Southern African countries, Consultant for UNICEF New York

May 2018 – Jun. 2019

Data collection and analysis of cost of diseases in the context of WHO Urban Health Initiative in Ghana, Consultant for WHO Geneva

May 2018 – May 2019

Rotavirus vaccine cost and budget impact analysis paper, Consultant/Technical Writer, PATH Seattle

2017-18

Monitoring and Evaluation Training of Trainers for Faculty of Muhimbili University of Health and Allied Sciences (MUHAS), Tanzania, Consultant for The Palladium Group (USA)

2017 - 2018

Cost-effectiveness of seasonal malaria chemoprevention in four West African countries (Burkina Faso, Niger, Nigeria, Mali), Senior Consultant for MSH (USA)

2016-2017

Cost-effectiveness of rotavirus vaccination in Ghana, Consultant/Technical Writer for PATH (Seattle)

2015 -2016

Cost-effectiveness analysis of seasonal malaria chemoprevention in Upper West Region of Ghana, Lead Consultant for UK DFID Ghana

2015 – Jun. 2016

An economic analysis of Ghana’s National Health Insurance Scheme electronic claims initiative, short term consultant for the World Bank (Washington)

2014

Costing of post-partum prevention strategy for Ghana, Consultant for PATH, Seattle